Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group.
about
Seletracetam (UCB 44212)The promise of new antiepileptic drugs.ECoG studies of valproate, carbamazepine and halothane in frontal-lobe epilepsy induced by head injury in the ratControversies in blood-level monitoring: reexamining its role in the treatment of epilepsy.Strategies for optimizing antiepileptic drug therapy in elderly people.Advancing the medical management of epilepsy: disease modification and pharmacogenetics.Antiepileptic and antiepileptogenic performance of carisbamate after head injury in the rat: blind and randomized studies.Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat.What we don't learn from clinical trials in epilepsy.The impact of epilepsy on subjective health status.Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy.Determining surgical candidacy in temporal lobe epilepsyEpilepsy--success in clinical practice: translating trials to practice.Diagnosing refractory epilepsy: response to sequential treatment schedules.Many options for epilepsy: comparisons of first- and second-generation AEDs.Long-term efficacy and safety of zonisamide monotherapy in epilepsy patients.Functional definition of seizure provides new insight into post-traumatic epileptogenesis.Factors predicting the outcome following surgical treatment of mesial temporal epilepsy due to mesial temporal sclerosis.Refractory epilepsy: one size does not fit all.Vigabatrin increases human brain homocarnosine and improves seizure control.The long-term prognosis of epilepsy patients with medically treated over a period of eight years in Turkey.Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy.Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.Synchrony levels during evoked seizure-like bursts in mouse neocortical slices.Broadening the perspective: treating the whole patient.Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.Epilepsy management. Issues in medical and surgical treatment.Epilepsy audit: do we document everything?
P2860
Q28281424-531FCECC-A8CC-4E95-B9A8-0D58255DF9DBQ30674774-5BDE7FD9-47E3-4BED-9154-9377E64A4361Q34005340-E8763CA2-A0AD-47C1-B9A2-4FD98B9BDB9BQ34090573-B4343DD4-CBA4-4564-BDA2-B074A5F18E6AQ34118987-B1158959-3DF2-4294-95C6-6D700000B674Q34579490-7A773FC1-C539-4218-A4EA-5033F1541749Q34702245-4AE27B39-B20A-47CE-9ED6-783DBB0462CEQ35083179-918E7A46-E378-47D2-BEBF-D5D6EB0EBEC9Q35200142-2577D5E2-4288-4EFD-B866-6292F4F2410DQ35204014-95F0FB83-21D9-484B-97C5-8A6956AD8FB7Q35592475-F388DFD5-E114-4430-BE82-27E61FA54817Q36168650-3D0BB100-8F0E-4866-9FE2-98E31EBFCA7FQ36249988-A8A3F2AC-CED0-45BB-9B6B-C814105288C5Q36450747-BBF19A58-44E7-478E-87D4-BDC01DF8A73CQ37203412-F5A27969-80DF-4ACD-8BA3-E27CFEC7D518Q37203512-41059E71-1DE2-4274-B6B4-95ABEC6C5B7DQ37381067-56AE5387-0005-4A9C-9B1C-B41A29AB4CD0Q38988033-35509357-4786-4D0D-9157-C610EA89DC2FQ42130961-C7E3B265-7F7D-40CC-923A-721FD59500B5Q42537668-549D9C8C-4FCD-44A9-9949-77F1FB3E4ACEQ42669771-50378DF0-B770-485E-8F6E-4C53767AF0CBQ43045028-543C196C-90C1-46A0-8274-CD22F1588F25Q44339785-4F3CC5ED-FC3F-477D-8AC3-F65B7ADDB588Q44443303-B0375E78-D0E4-4596-97EF-9B54E2763BAFQ44511983-0F6D4B7E-E26A-4D0F-9BB6-8AF668C771FEQ46690494-6F441DC4-DE68-4228-9419-B4BF00AA646AQ48671534-56594097-0CBA-4D17-970A-8559411B893FQ51549304-E852DB87-1B25-454C-82E1-2338F62081B0
P2860
Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Prognosis for total control of ...... ies No. 118 and No. 264 Group.
@en
Prognosis for total control of ...... ies No. 118 and No. 264 Group.
@nl
type
label
Prognosis for total control of ...... ies No. 118 and No. 264 Group.
@en
Prognosis for total control of ...... ies No. 118 and No. 264 Group.
@nl
prefLabel
Prognosis for total control of ...... ies No. 118 and No. 264 Group.
@en
Prognosis for total control of ...... ies No. 118 and No. 264 Group.
@nl
P2093
P356
P1433
P1476
Prognosis for total control of ...... ies No. 118 and No. 264 Group.
@en
P2093
P356
10.1212/WNL.47.1.68
P407
P577
1996-07-01T00:00:00Z